Assessment of the impact of the new blister packaging of Biktarvy(R) (B/F/TAF) on treatment satisfaction of people living with HIV. Cruz JP, Santos O, Rodrigues M, Morais R, et al. PLoS One 2025;20:e0313458.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cruz JP, Santos O, Rodrigues M, Morais R, et al. Assessment of the impact of the new blister packaging of Biktarvy(R) (B/F/TAF) on treatment satisfaction of people living with HIV. PLoS One 2025;20:e0313458.
PMID: 41401148